Does Perioperative Pregabalin Reduce Postoperative Pain After Arthroscopic Anterior Cruciate Ligament Reconstruction Surgery Under Spinal Anesthesia?
NCT ID: NCT03211728
Last Updated: 2019-02-20
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
96 participants
INTERVENTIONAL
2017-07-19
2019-02-08
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Efficacy And Safety Of Pregabalin For Pain Following Total Knee Replacement
NCT00442546
Effects of Pregabalin on Pain After Total Knee Arthroplasty
NCT01333956
Reducing Postoperative Side Effect of Pregabalin
NCT04599894
The Effect of Pregabalin on the Spinal Anesthesia
NCT02690506
The Clinical Effect of Pregabalin on Neuropathic Pain in Non Central Sensitized Patients After Total Knee Arthroplasty
NCT05322681
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
PREVENTION
QUADRUPLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
experimental group
pregabalin
The intervention group receive pregabalin 150 mg 1 hour before surgery and 12 hours after initial dose.
placebo group
placebo
The placebo group receive placebo 150 mg 1 hour before surgery and 12 hours after initial dose.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
pregabalin
The intervention group receive pregabalin 150 mg 1 hour before surgery and 12 hours after initial dose.
placebo
The placebo group receive placebo 150 mg 1 hour before surgery and 12 hours after initial dose.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* physical condition type I or II in ASA (American Society of Anesthesiology)
Exclusion Criteria
* with a history of cardiovascular or respiratory disease
* dizziness or frequent headache
* active alcohol or drug usage,
* intake of any analgesics daily or 48 hours before surgery
* impaired renal and/or hepatic function
20 Years
65 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Yonsei University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Department of Anesthesiology and Pain Medicine, Anesthesia and Pain Research Institue, Yonsei Universiy College of Medicine
Seoul, , South Korea
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
4-2017-0415
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.